Ira D Glick

Summary

Affiliation: Stanford University
Country: USA

Publications

  1. doi request reprint The role of the family and improvement in treatment maintenance, adherence, and outcome for schizophrenia
    Ira D Glick
    Psychiatry and Behavioral Sciences, Schizophrenia Research Program, Stanford University School of Medicine, Stanford, CA, USA
    J Clin Psychopharmacol 31:82-5. 2011
  2. doi request reprint Mid-term and long-term efficacy and effectiveness of antipsychotic medications for schizophrenia: a data-driven, personalized clinical approach
    Ira D Glick
    Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, California, USA
    J Clin Psychiatry 72:1616-27. 2011
  3. ncbi request reprint Concomitant medications may not improve outcome of antipsychotic monotherapy for stabilized patients with nonacute schizophrenia
    Ira D Glick
    Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, CA 94305, USA
    J Clin Psychiatry 67:1261-5. 2006
  4. doi request reprint The efficacy, safety, and tolerability of aripiprazole for the treatment of schizoaffective disorder: results from a pooled analysis of a sub-population of subjects from two randomized, double-blind, placebo-controlled, pivotal trials
    Ira D Glick
    Department of Psychiatry and Behavioral Sciences, and Psychopharmacology, Stanford University School of Medicine, Stanford, CA, USA
    J Affect Disord 115:18-26. 2009
  5. ncbi request reprint Aripiprazole in schizophrenia patients with comorbid obsessive-compulsive symptoms: an open-label study of 15 patients
    Ira D Glick
    Stanford University School of Medicine, Department of Psychiatry, 401 Quarry Rd, Suite 2122, Stanford, CA 94305, USA
    J Clin Psychiatry 69:1856-9. 2008
  6. doi request reprint A double-blind randomized trial of mood stabilizer augmentation using lamotrigine and valproate for patients with schizophrenia who are stabilized and partially responsive
    Ira D Glick
    Department of Psychiatry, Schizophrenia Clinic, Stanford University School of Medicine, Stanford, CA, USA
    J Clin Psychopharmacol 29:267-71. 2009
  7. ncbi request reprint Differential early onset of therapeutic response with risperidone vs conventional antipsychotics in patients with chronic schizophrenia
    Ira D Glick
    Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford University Medical Center, Stanford, CA 94305, USA
    Int Clin Psychopharmacol 21:261-6. 2006
  8. ncbi request reprint Long-term maintenance therapy with quetiapine versus haloperidol decanoate in patients with schizophrenia or schizoaffective disorder
    Ira D Glick
    Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, 101 Quarry Road 2122, Stanford, CA 94305, USA
    J Clin Psychiatry 66:638-41. 2005
  9. doi request reprint Onset and persistence of antipsychotic response in patients with schizophrenia
    Ira D Glick
    Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Suite 2122, 401 Quarry Rd, Stanford, CA 94305, USA
    J Clin Psychopharmacol 29:542-7. 2009
  10. ncbi request reprint Metabolic impact of switching antipsychotic therapy to aripiprazole after weight gain: a pilot study
    Sun H Kim
    Division of Endocrinology, Stanford University, Stanford, CA, USA
    J Clin Psychopharmacol 27:365-8. 2007

Detail Information

Publications18

  1. doi request reprint The role of the family and improvement in treatment maintenance, adherence, and outcome for schizophrenia
    Ira D Glick
    Psychiatry and Behavioral Sciences, Schizophrenia Research Program, Stanford University School of Medicine, Stanford, CA, USA
    J Clin Psychopharmacol 31:82-5. 2011
    ....
  2. doi request reprint Mid-term and long-term efficacy and effectiveness of antipsychotic medications for schizophrenia: a data-driven, personalized clinical approach
    Ira D Glick
    Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, California, USA
    J Clin Psychiatry 72:1616-27. 2011
    ....
  3. ncbi request reprint Concomitant medications may not improve outcome of antipsychotic monotherapy for stabilized patients with nonacute schizophrenia
    Ira D Glick
    Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, CA 94305, USA
    J Clin Psychiatry 67:1261-5. 2006
    ..To our knowledge, there have been no published reports of prospective systematic investigations of the efficacy of unrestricted CPM use in nonacute schizophrenia...
  4. doi request reprint The efficacy, safety, and tolerability of aripiprazole for the treatment of schizoaffective disorder: results from a pooled analysis of a sub-population of subjects from two randomized, double-blind, placebo-controlled, pivotal trials
    Ira D Glick
    Department of Psychiatry and Behavioral Sciences, and Psychopharmacology, Stanford University School of Medicine, Stanford, CA, USA
    J Affect Disord 115:18-26. 2009
    ..Because efficacy may be better in schizoaffective disorder than schizophrenia, this post-hoc analysis examines the efficacy, safety, and tolerability of aripiprazole in patients with schizoaffective disorder...
  5. ncbi request reprint Aripiprazole in schizophrenia patients with comorbid obsessive-compulsive symptoms: an open-label study of 15 patients
    Ira D Glick
    Stanford University School of Medicine, Department of Psychiatry, 401 Quarry Rd, Suite 2122, Stanford, CA 94305, USA
    J Clin Psychiatry 69:1856-9. 2008
    ..This study examined aripiprazole treatment of patients with comorbid schizophrenia and obsessive-compulsive symptoms (OCS) that did not meet full criteria for OCD...
  6. doi request reprint A double-blind randomized trial of mood stabilizer augmentation using lamotrigine and valproate for patients with schizophrenia who are stabilized and partially responsive
    Ira D Glick
    Department of Psychiatry, Schizophrenia Clinic, Stanford University School of Medicine, Stanford, CA, USA
    J Clin Psychopharmacol 29:267-71. 2009
    ..To compare the efficacy of mood stabilizer augmentation of an antipsychotic for patients with schizophrenia who are both stabilized and partially responsive...
  7. ncbi request reprint Differential early onset of therapeutic response with risperidone vs conventional antipsychotics in patients with chronic schizophrenia
    Ira D Glick
    Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford University Medical Center, Stanford, CA 94305, USA
    Int Clin Psychopharmacol 21:261-6. 2006
    ..1-1.5). These findings are clinically relevant because the faster onset of therapeutic effect with atypical antipsychotics can be important in the acute setting and have a considerable impact on healthcare systems...
  8. ncbi request reprint Long-term maintenance therapy with quetiapine versus haloperidol decanoate in patients with schizophrenia or schizoaffective disorder
    Ira D Glick
    Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, 101 Quarry Road 2122, Stanford, CA 94305, USA
    J Clin Psychiatry 66:638-41. 2005
    ..To compare the long-term efficacy and tolerability of oral quetiapine with those of intramuscular haloperidol...
  9. doi request reprint Onset and persistence of antipsychotic response in patients with schizophrenia
    Ira D Glick
    Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Suite 2122, 401 Quarry Rd, Stanford, CA 94305, USA
    J Clin Psychopharmacol 29:542-7. 2009
    ..Results suggest that persistent response requires continuing antipsychotic treatment beyond 2 weeks in some patients. These results may be useful for clinical decision making and patient education...
  10. ncbi request reprint Metabolic impact of switching antipsychotic therapy to aripiprazole after weight gain: a pilot study
    Sun H Kim
    Division of Endocrinology, Stanford University, Stanford, CA, USA
    J Clin Psychopharmacol 27:365-8. 2007
    ..In conclusion, switching to aripiprazole alone does not ameliorate the highly prevalent metabolic abnormalities in the schizophrenia population who have gained weight on other second generation antipsychotic medications...
  11. ncbi request reprint Psychiatric conditions in sports: diagnosis, treatment, and quality of life
    Ira D Glick
    Stanford University School of Medicine, 401 Quarry Road, Suite 2122, Stanford, CA 94305, USA
    Phys Sportsmed 37:29-34. 2009
    ..Confidentiality issues are paramount during diagnosis and treatment. Physicians who understand sports and team dynamics may have more success in helping patients follow through with treatment...
  12. ncbi request reprint Patterns of concomitant psychotropic medication use during a 2-year study comparing clozapine and olanzapine for the prevention of suicidal behavior
    Ira D Glick
    Stanford University School of Medicine, Stanford, California, USA
    J Clin Psychiatry 65:679-85. 2004
    ..This article describes the use patterns of CPMs during InterSePT and examines whether CPM use may have affected study outcome...
  13. ncbi request reprint Understanding the results of CATIE in the context of the field
    Ira D Glick
    Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, CA 94305, USA
    CNS Spectr 11:40-7. 2006
    ..What should emerge from CATIE is a renewed commitment to tailor schizophrenia treatment to the individual patient for long-term management...
  14. doi request reprint Managing psychiatric issues in elite athletes
    Ira D Glick
    Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, California, USA
    J Clin Psychiatry 73:640-4. 2012
    ..These patients present with multifaceted medical, psychological, and performance concerns. We provide the first report of professional and ethical quandaries that arise in treating elite athletes and ways to address them...
  15. doi request reprint Teaching pearls from the lost art of psychopharmacology
    Ira D Glick
    Stanford University School of Medicine, USA
    J Psychiatr Pract 15:423-6. 2009
    ..In this article, the authors present their collection of psychopharmacology "pearls" for trainees as well as experienced clinicians. (Journal of Psychiatric Practice 2009;15:423-426)...
  16. doi request reprint The evolution of sport psychiatry, circa 2009
    Ira D Glick
    Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, California, USA
    Sports Med 39:607-13. 2009
    ..Case examples, a training curriculum and core literature are included...
  17. ncbi request reprint Combining pharmacotherapy with psychotherapeutic management: guidelines for integration
    Ira D Glick
    Stanford University School of Medicine, CA, USA
    J Clin Psychiatry 67:1645-6. 2006
  18. doi request reprint Inpatient psychiatric care in the 21st century: the need for reform
    Ira D Glick
    Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, California, USA
    Psychiatr Serv 62:206-9. 2011
    ..Three phases are described--assessment, implementation, and resolution--with specific principles to guide length-of-stay decisions and requirements for staffing...